Paxlovid Drug Interactions and Clinical Considerations

Introduction to Paxlovid Interactions

Ritonavir, a component of Paxlovid, is a strong CYP3A inhibitor and perpetrator of many drug-drug interactions, warranting serious consideration before prescribing Paxlovid, as noted by the British Medical Journal 1, 2, 3

The American College of Cardiology recommends avoiding the use of antiarrhythmics such as amiodarone, flecainide, and propafenone with Paxlovid due to high-risk interactions 4
The use of anticoagulants like rivaroxaban with Paxlovid is contraindicated due to increased risk of bleeding, as reported in Clinical and Molecular Hepatology 5
Statins such as lovastatin and simvastatin should be avoided with Paxlovid due to increased risk of myopathy, according to the American Academy of Family Physicians 6

The British Medical Journal suggests always checking for drug interactions before prescribing Paxlovid using resources like the Liverpool COVID-19 Drug Interaction Tool, and monitoring patients closely for adverse effects when Paxlovid is co-administered with medications that cannot be temporarily discontinued 1, 3
The duration of interaction risk extends beyond the 5-day treatment period due to ritonavir's effects on metabolism and clearance, as noted by the British Medical Journal 1, 2
The British Medical Journal reports that common adverse effects of Paxlovid include dysgeusia, diarrhea, and potential hepatotoxicity 3

The American College of Cardiology recommends monitoring for symptoms of myopathy (muscle pain, tenderness, or weakness) if any statin is continued during Paxlovid treatment 7
Patients on atorvastatin should be monitored for liver function abnormalities when co-administered with Paxlovid, as recommended by Kidney International 8

Pravastatin or fluvastatin may be considered as alternative statins during Paxlovid treatment if lipid-lowering therapy cannot be interrupted, due to their minimal dependence on CYP3A4 metabolism 7